Fixed Low-Dose Hydroxyurea for the Treatment of Adults with Sickle Cell Anemia in Nigeria

Am J Hematol. 2018 May 14:10.1002/ajh.25143. doi: 10.1002/ajh.25143. Online ahead of print.

Authors

Bamidele O Tayo¹, Titilola S Akingbola², Santosh L Saraf³, Binal N Shah³, Chinedu A Ezekekwu², Omowunmi Sonubi², Lewis L Hsu⁴, Richard S Cooper¹, Victor R Gordeuk³

Affiliations

¹ Department of Public Health Sciences, Loyola University Chicago Stritch School of Medicine, Maywood, IL.
² Department of Hematology, College of Medicine, University of Ibadan, Ibadan, Nigeria.
³ Division of Hematology & Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL.
⁴ Division of Pediatric Hematology-Oncology, Department of Pediatrics, University of Illinois at Chicago, Chicago, IL.

No abstract available

Keywords: Hydroxyurea; fixed low dose; sickle cell anemia; sickle cell disease.

Publication types

Letter

Grants and funding

2013140/DDCF/Doris Duke Charitable Foundation/United States